Oxygen Concentrators Market By Type (Portable Oxygen Concentrators, Stationary Oxygen Concentrators), By Technology (Continuous Flow Oxygen Concentrators, Pulse Dose Oxygen Concentrators), By End-Use Industry (Homecare, Hospitals, Ambulatory Surgical Centers, Long-term Care Facilities), By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Disorders), By Flow Rate (Low Flow (1-5 LPM), High Flow (Above 5 LPM)), and By Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Oxygen Concentrators Market was valued at USD 2.0 billion in 2023 and will surpass USD 4.5 billion by 2030; growing at a CAGR of 12.3% during 2024 - 2030.

The oxygen concentrators market has been experiencing significant growth driven by the increasing prevalence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and other chronic respiratory disorders. These devices, which provide a continuous supply of oxygen, are essential for patients requiring supplemental oxygen therapy. With advancements in technology and a growing aging population, the demand for oxygen concentrators, particularly in homecare settings, has surged.

Moreover, the rise in awareness about respiratory health and the need for cost-effective alternatives to traditional oxygen tanks has propelled the adoption of both portable and stationary oxygen concentrators. The market's expansion is also fueled by increasing healthcare accessibility, improved treatment options, and the push towards home healthcare solutions, which offer convenience and lower long-term costs for patients.

Portable Oxygen Concentrators are Fastest Growing Due to Demand for Mobility

Portable oxygen concentrators (POCs) are the fastest growing segment within the oxygen concentrators market. This growth is largely attributed to the increasing need for mobility among patients with chronic respiratory conditions, particularly COPD and asthma. POCs offer patients the flexibility to carry their oxygen supply wherever they go, making them ideal for individuals with active lifestyles who require constant oxygen support. These devices are lightweight, compact, and designed for easy transport, which has made them highly popular for homecare and ambulatory uses.

Additionally, advancements in battery technology and design have further enhanced the portability and functionality of these devices, leading to greater adoption. As the preference for home-based and ambulatory healthcare solutions increases, portable oxygen concentrators are expected to continue their growth trajectory, meeting the needs of a broader patient demographic.

Continuous Flow Oxygen Concentrators are Largest Due to Established Efficacy in Treatment

Continuous flow oxygen concentrators hold the largest market share, primarily due to their established efficacy in providing a consistent flow of oxygen, making them the preferred choice for patients with severe respiratory conditions. These concentrators are typically used in homecare and hospital settings, where the need for a constant, uninterrupted oxygen supply is critical. The devices are especially beneficial for patients who require oxygen therapy for extended periods, such as those with advanced stages of COPD.

While pulse dose oxygen concentrators are growing in popularity, particularly among mobile patients, continuous flow systems remain the standard due to their reliability and the fact that they can provide higher oxygen flow rates. As the market focuses on treating patients with severe chronic respiratory conditions, continuous flow systems continue to lead the oxygen concentrator market.

Homecare End-Use Industry is Largest Due to Growing Preference for At-Home Treatment

The homecare end-use industry holds the largest share of the oxygen concentrators market, driven by the growing preference for home-based healthcare solutions. More patients with chronic respiratory diseases are opting for at-home treatment as it offers the convenience of managing their condition in a familiar environment, while reducing the need for hospital visits. This trend is particularly evident in aging populations, where patients often prefer homecare services to avoid the discomfort and cost of long-term hospital stays.

Additionally, homecare settings benefit from the use of portable oxygen concentrators, as they allow patients to remain mobile and active, thus improving their quality of life. The shift towards home healthcare is expected to continue to rise, further driving the demand for oxygen concentrators in the homecare segment.

North America Region is Largest Due to Advanced Healthcare Infrastructure

North America is the largest region in the oxygen concentrators market, owing to its advanced healthcare infrastructure, high rates of chronic respiratory diseases, and strong adoption of homecare technologies. The U.S., in particular, has a high prevalence of COPD and asthma, leading to a greater need for oxygen therapy devices. The region also benefits from a robust healthcare system that supports access to advanced medical equipment, including both portable and stationary oxygen concentrators.

The demand for oxygen concentrators in North America is further supported by favorable reimbursement policies and increasing awareness about the benefits of home-based oxygen therapy. As the region continues to lead in healthcare innovation and patient care, it is expected to maintain its dominance in the global oxygen concentrators market.

Competitive Landscape: Leading Companies and Market Dynamics

The oxygen concentrators market is highly competitive, with leading players such as Philips Healthcare, Invacare Corporation, and ResMed Inc. dominating the industry. These companies are focusing on product innovations, expanding their product portfolios, and enhancing customer service to maintain market leadership. They are also investing in research and development to improve the performance, portability, and efficiency of oxygen concentrators, which has led to advancements in battery life, oxygen delivery mechanisms, and overall device design.

The competitive landscape is further shaped by the increasing trend of homecare and ambulatory healthcare, prompting companies to develop portable solutions that cater to the mobility needs of patients. As demand for oxygen therapy devices rises globally, manufacturers are expected to continue introducing cutting-edge technologies to capture a larger market share, ensuring that patients receive the best possible care and treatment for their respiratory conditions.

List of Leading Companies:

• Philips Healthcare
• Inogen Inc.
• ResMed
• AirSep Corporation (Chart Industries)
• Invacare Corporation
• Drägerwerk AG & Co. KGaA
• Nidek Medical Products
• Oxlife (O2 Concepts)
• O2 Concepts LLC
• Linde Healthcare
• GF Health Products, Inc.
• Medtronic
• Vyaire Medical, Inc.
• Nihon Kohden Corporation
• CareFusion Corporation (BD)

Recent Developments:

• In November 2024, Philips Healthcare launched a new portable oxygen concentrator designed to be lighter and more energy-efficient, improving patient mobility.
• In October 2024, ResMed introduced an advanced stationary oxygen concentrator with enhanced oxygen output and quieter operation for long-term care facilities.
• In September 2024, Inogen Inc. announced the expansion of its product range with the launch of a new portable oxygen concentrator equipped with a long-lasting battery for extended use.
• In August 2024, AirSep Corporation (Chart Industries) unveiled a high-flow oxygen concentrator targeted at patients with more severe respiratory conditions, offering higher oxygen delivery.
• In July 2024, Medtronic launched a pulse dose oxygen concentrator with smart connectivity features, allowing users to track their oxygen usage and adjust settings remotely.

Report Scope: